Kelly Blackburn

Kelly Blackburn

Chief Tech/Sci/R&D Officer at CERVOMED INC.

Net worth: 35 279 $ as of 31/07/2026

61 year
Health Technology
Consumer Services
Commercial Services

Profile

Kelly Blackburn currently works at Bach Pharma, Inc., as Chief Executive Officer & Director from 2016 and CervoMed, Inc., as Executive Vice President-Clinical Development from 2025.
Ms. Blackburn also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Clinical & Safety Operations from 2002 to 2006, aTyr Pharma, Inc., as Vice President-Clinical Affairs from 2013 to 2016, Vertex Pharmaceuticals, Inc., as Vice President-Clinical Development Operations from 2006 to 2012, and EIP Pharma, Inc., as Senior Vice President-Clinical Development from 2018 to 2023.
Ms. Blackburn received her undergraduate degree from the University of New Hampshire, graduate degree from Quinnipiac College, Inc., and graduate degree from Cambridge College Lima SRL.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/04/2026 13,674 ( 0.09% ) 35 279 $ 31/07/2026

Kelly Blackburn active positions

CompaniesPositionStart
CERVOMED INC. Chief Tech/Sci/R&D Officer 16/08/2023
Chief Executive Officer 15/07/2016

Former positions of Kelly Blackburn

CompaniesPositionEnd
Corporate Officer/Principal 01/08/2023
ATYR PHARMA, INC. Chief Tech/Sci/R&D Officer 01/07/2016
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/09/2012
Corporate Officer/Principal 01/08/2006
See the detail of Kelly Blackburn's experience

Training of Kelly Blackburn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Kelly Blackburn